Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 325 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Smilow Cancer Hospital at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Analog Device, Inc.
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: SWOG Cancer Research Network
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Mercy Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0263 - Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Stroke, Stroke, Acute
N/A
Observational 1,060 participants sought
Hartford Health Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Cincinnati
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Hartford, Connecticut (25.4 mi)
· Sponsor: Medtronic
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Army-SPRING Army-Suicide Prevention Research
Suicide
Phase 1
Interventional 57 participants sought
Connecticut Army National Guard — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Pennsylvania
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Pediatric Cancer, Adolescent and Young Adult Cancer
N/A
Interventional 60 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Connecticut Children's Medical Center
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Stage III Ovarian Cancer, Stage IV Ovarian Cancer
Phase 3
Interventional 220 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: GOG Foundation
Target ADHD Executive Working Memory Replication Study
ADHD
N/A
Interventional 130 participants sought
Institute of Living/Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hartford Hospital
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
HPV-Related Squamous Cell Carcinoma
Phase 3
Interventional 291 participants sought
Hartford Healthcare (Data Collection Only) — Hartford, Connecticut (25.4 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Crohn's Disease
Phase 3
Interventional 90 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Eli Lilly and Company